Technical Analysis for TSBX - Turnstone Biologics Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -2.56% | |
| MACD Bearish Signal Line Cross | Bearish | -2.56% | |
| Bollinger Band Squeeze | Range Contraction | -2.56% | |
| Doji - Bullish? | Reversal | -2.56% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Possible Inside Day | 1 day ago |
| Up 2% | 2 days ago |
| 60 Minute Opening Range Breakout | 2 days ago |
| Up 1% | 2 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 02/28/2024
Turnstone Biologics Corp. Description
Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.2 |
| 52 Week Low | 1.625 |
| Average Volume | 178,776 |
| 200-Day Moving Average | 3.91 |
| 50-Day Moving Average | 2.96 |
| 20-Day Moving Average | 2.87 |
| 10-Day Moving Average | 2.94 |
| Average True Range | 0.33 |
| RSI (14) | 43.18 |
| ADX | 15.8 |
| +DI | 16.13 |
| -DI | 19.26 |
| Chandelier Exit (Long, 3 ATRs) | 2.41 |
| Chandelier Exit (Short, 3 ATRs) | 3.44 |
| Upper Bollinger Bands | 3.26 |
| Lower Bollinger Band | 2.47 |
| Percent B (%b) | 0.24 |
| BandWidth | 27.57 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0134 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.93 | ||||
| Resistance 3 (R3) | 2.94 | 2.87 | 2.89 | ||
| Resistance 2 (R2) | 2.87 | 2.80 | 2.86 | 2.87 | |
| Resistance 1 (R1) | 2.76 | 2.76 | 2.73 | 2.75 | 2.85 |
| Pivot Point | 2.69 | 2.69 | 2.67 | 2.68 | 2.69 |
| Support 1 (S1) | 2.58 | 2.62 | 2.55 | 2.57 | 2.47 |
| Support 2 (S2) | 2.51 | 2.58 | 2.50 | 2.45 | |
| Support 3 (S3) | 2.40 | 2.51 | 2.44 | ||
| Support 4 (S4) | 2.39 |
